[go: up one dir, main page]

WO2007031140A3 - Extrakte aus epimedium-arten, verfahren zu ihrer herstellung und verwendung - Google Patents

Extrakte aus epimedium-arten, verfahren zu ihrer herstellung und verwendung Download PDF

Info

Publication number
WO2007031140A3
WO2007031140A3 PCT/EP2006/006929 EP2006006929W WO2007031140A3 WO 2007031140 A3 WO2007031140 A3 WO 2007031140A3 EP 2006006929 W EP2006006929 W EP 2006006929W WO 2007031140 A3 WO2007031140 A3 WO 2007031140A3
Authority
WO
WIPO (PCT)
Prior art keywords
extracts
production
oestrogen
special purpose
epimedium species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2006/006929
Other languages
English (en)
French (fr)
Other versions
WO2007031140A2 (de
Inventor
Egon Koch
Clemens Erdelmeier
Hermann Hauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Willmar Schwabe GmbH and Co KG
Original Assignee
Dr Willmar Schwabe GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe GmbH and Co KG filed Critical Dr Willmar Schwabe GmbH and Co KG
Priority to EP06828796A priority Critical patent/EP1904075A2/de
Publication of WO2007031140A2 publication Critical patent/WO2007031140A2/de
Publication of WO2007031140A3 publication Critical patent/WO2007031140A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296—Epimedium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Die vorliegende Erfindung betrifft Spezialextrakte (Flüssigund Trockenextrakte) aus Epimedium-Arten, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel und Lebensmittel, insbesondere diätetische Lebensmittel, Nahrungsergänzungsmittel sowie „Medical Food“ und „Dietary Supplements“, und Verwendung der Spezialextrakte zur Prophylaxe und Behandlung von Krankheitszuständen, die durch einen Mangel an Östrogenen oder durch eine Dysregulation des Geschlechtshormonstoffwechsels, insbesondere des Östrogenstoffwechsels verursacht werden.
PCT/EP2006/006929 2005-07-15 2006-07-14 Extrakte aus epimedium-arten, verfahren zu ihrer herstellung und verwendung Ceased WO2007031140A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06828796A EP1904075A2 (de) 2005-07-15 2006-07-14 Extrakte aus epimedium-arten, verfahren zu ihrer herstellung und verwendung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005033241 2005-07-15
DE102005033241.2 2005-07-15

Publications (2)

Publication Number Publication Date
WO2007031140A2 WO2007031140A2 (de) 2007-03-22
WO2007031140A3 true WO2007031140A3 (de) 2007-08-09

Family

ID=37865295

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/006929 Ceased WO2007031140A2 (de) 2005-07-15 2006-07-14 Extrakte aus epimedium-arten, verfahren zu ihrer herstellung und verwendung

Country Status (2)

Country Link
EP (1) EP1904075A2 (de)
WO (1) WO2007031140A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104001004A (zh) * 2014-06-16 2014-08-27 徐艳 一种治疗骨折和骨质疏松的中药组合物及其制备方法和应用
CN105214012A (zh) * 2015-11-16 2016-01-06 陈明海 一种治疗乳腺增生的中药组合物
CN112552356A (zh) * 2020-06-29 2021-03-26 郑州福瑞堂制药有限公司 一种淫羊藿苷制备方法
CN113980065A (zh) * 2021-11-09 2022-01-28 陕西理工大学 从淫羊藿全草中提取淫羊藿苷的方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071883A (en) * 1998-07-28 2000-06-06 Chen; Huifang Flavone analogues useful as anti-rejection agents
US20020013280A1 (en) * 2000-06-16 2002-01-31 Zhongcheng Xin Pharmaceutical composition for preventing and treating sexual dysfunction and vasculargenic disease comprising icariin
WO2002013842A1 (en) * 2000-08-15 2002-02-21 Hauser, Inc. Compositions comprising icariside i and anhydroicaritin and methods for making the same
US6476203B1 (en) * 2002-03-14 2002-11-05 Xinxian Zhao Safe pharmaceutical composition for treating and preventing infertility and increasing immune function
CN1403468A (zh) * 2002-09-26 2003-03-19 中国药科大学 具有抗骨质疏松作用的淫羊藿总黄酮的制备方法
US20030153515A1 (en) * 1999-06-17 2003-08-14 Zhongcheng Xin Method for prevention and treatment of male and female sexual dysfunction
US20030170292A1 (en) * 2001-11-09 2003-09-11 National University Of Singapore Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071883A (en) * 1998-07-28 2000-06-06 Chen; Huifang Flavone analogues useful as anti-rejection agents
US20030153515A1 (en) * 1999-06-17 2003-08-14 Zhongcheng Xin Method for prevention and treatment of male and female sexual dysfunction
US20020013280A1 (en) * 2000-06-16 2002-01-31 Zhongcheng Xin Pharmaceutical composition for preventing and treating sexual dysfunction and vasculargenic disease comprising icariin
WO2002013842A1 (en) * 2000-08-15 2002-02-21 Hauser, Inc. Compositions comprising icariside i and anhydroicaritin and methods for making the same
US20030170292A1 (en) * 2001-11-09 2003-09-11 National University Of Singapore Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
US6476203B1 (en) * 2002-03-14 2002-11-05 Xinxian Zhao Safe pharmaceutical composition for treating and preventing infertility and increasing immune function
CN1403468A (zh) * 2002-09-26 2003-03-19 中国药科大学 具有抗骨质疏松作用的淫羊藿总黄酮的制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200354, Derwent World Patents Index; AN 2003-569805, XP002428387 *
MENG F H ET AL: "Osteoblastic proliferative activity of Epimedium brevicornum Maxim", PHYTOMEDICINE, GUSTAV FISCHER VERLAG, STUTTGART, DE, vol. 12, no. 3, 22 March 2005 (2005-03-22), pages 189 - 193, XP004957235, ISSN: 0944-7113 *
MENG FANHAO ET AL: "OSTEOBLASTIC PROLIFERATION STIMULATING ACTIVITY OF EPIMEDIUM KOREANUM NAKAI EXTRACTS AND ITS FLAVONOL GLYCOSIDES", PHARMACEUTICAL BIOLOGY, SWETS AND ZEITLINGER, LISSE,, NL, vol. 43, no. 1, January 2005 (2005-01-01), pages 92 - 95, XP009081516, ISSN: 1388-0209 *

Also Published As

Publication number Publication date
EP1904075A2 (de) 2008-04-02
WO2007031140A2 (de) 2007-03-22

Similar Documents

Publication Publication Date Title
WO2009047754A3 (en) Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation
PH12012501348A1 (en) Nutritional emulsions comprising calcium hmb and soluble protein
WO2007113008A3 (en) Opaque container comprising food or pharmaceutical products or herbal(s)
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
NO20085374L (no) Anvendelse av fytat som middel for a inhibere opplosning av krystaller av kalsiumsalter for forhindring av osteoporose
ATE453642T1 (de) Substituierte phenylaminopyrimidine
WO2008066380A3 (en) Process for the preparation of powdered oils
WO2007113291A3 (en) Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
WO2010055490A3 (en) Phytocomplex from bergamot fruit, process of manufacture and use as dietary supplement and in the pharmaceutical field
WO2008096203A3 (en) Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
WO2006108582A3 (en) Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis
FI20065593A7 (fi) Menetelmä galakto-oligosakkarideja sisältävien tuotteiden valmistamiseksi ja niiden käyttö
WO2009091120A3 (en) Composition comprising the extracts of lindera obtusiloba for prevention and treatment of cardiovascular diseases
HUP0300732A2 (hu) Chlamydiás fertżzések kezelésében és megelżzésében hatékony növényi-eredetż és szintetikus fenolos vegyületek és növényi extraktumok
NO20083307L (no) Anvendelse av et ikke-forsapbart ekstrakt fra plantemasse ved behandling av hudaldring
TW200724532A (en) Pyrimidinecarboxylic acid derivatives and their use
WO2009053628A3 (fr) Nouveaux composes, préparation et utilisations
TW200612903A (en) Use of trisubstituted benzopyranones
AU2011343331A8 (en) Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
WO2007031140A3 (de) Extrakte aus epimedium-arten, verfahren zu ihrer herstellung und verwendung
WO2007038596A3 (en) Phytosterol nutritional supplements
IN2014MN00932A (de)
ATE452120T1 (de) Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2006828796

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 2006828796

Country of ref document: EP